These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2209062)

  • 1. Potential value of collagen shields as a subconjunctival depot release system.
    Finkelstein I; Trope GE; Menon IA; Rootman DS; Basu PK
    Curr Eye Res; 1990 Jul; 9(7):653-9. PubMed ID: 2209062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evaluation of collagen shields as a delivery system for 5-fluorouracil: histopathological observations.
    Finkelstein I; Trope GE; Heathcote JG; Rootman DS; Spero L; Menon IA
    Can J Ophthalmol; 1991 Apr; 26(3):129-32. PubMed ID: 2054722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide).
    Wang G; Tucker IG; Roberts MS; Hirst LW
    Pharm Res; 1996 Jul; 13(7):1059-64. PubMed ID: 8842045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen shields impregnated with gentamicin-dexamethasone as a potential drug delivery device.
    Milani JK; Verbukh I; Pleyer U; Sumner H; Adamu SA; Halabi HP; Chou HJ; Lee DA; Mondino BJ
    Am J Ophthalmol; 1993 Nov; 116(5):622-7. PubMed ID: 8238224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery.
    Cui LJ; Sun NX; Li XH; Huang J; Yang JG
    Acta Pharmacol Sin; 2008 Sep; 29(9):1021-8. PubMed ID: 18718170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A pharmacokinetic study of subconjunctival polyphase liposome 5-fluorouracil].
    Ke XF; Wei HR; Yang JX
    Zhonghua Yan Ke Za Zhi; 1994 Mar; 30(2):128-30. PubMed ID: 8001446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro release.
    Zignani M; Einmahl S; Baeyens V; Varesio E; Veuthey JL; Anderson J; Heller J; Tabatabay C; Gurny R
    Eur J Pharm Biopharm; 2000 Sep; 50(2):251-5. PubMed ID: 10962235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen shield drug delivery: therapeutic concentrations of tobramycin in the rabbit cornea and aqueous humor.
    Unterman SR; Rootman DS; Hill JM; Parelman JJ; Thompson HW; Kaufman HE
    J Cataract Refract Surg; 1988 Sep; 14(5):500-4. PubMed ID: 3183930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subconjunctival sustained release 5-fluorouracil.
    Blandford DL; Smith TJ; Brown JD; Pearson PA; Ashton P
    Invest Ophthalmol Vis Sci; 1992 Nov; 33(12):3430-5. PubMed ID: 1428716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fifty:fifty poly (DL glycolic acid-lactic acid) copolymer as a drug delivery system for 5-fluorouracil: a histopathological evaluation.
    Gould L; Trope G; Cheng YL; Heathcote JG; Sheardown H; Rootman D; Liu GS; Menon IA
    Can J Ophthalmol; 1994 Aug; 29(4):168-71. PubMed ID: 7994670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sponge delivery variables and tissue levels of 5-fluorouracil.
    Wilkins MR; Occleston NL; Kotecha A; Waters L; Khaw PT
    Br J Ophthalmol; 2000 Jan; 84(1):92-7. PubMed ID: 10611106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with bevacizumab and 5-fluorouracil attenuates the postoperative scarring response after experimental glaucoma filtration surgery.
    How A; Chua JL; Charlton A; Su R; Lim M; Kumar RS; Crowston JG; Wong TT
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):928-32. PubMed ID: 19797222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow release of the antimetabolite 5-fluorouracil (5-FU) from modified Baerveldt glaucoma drains to prolong drain function.
    Jacob JT; Lacour OJ; Burgoyne CF
    Biomaterials; 2001 Dec; 22(24):3329-35. PubMed ID: 11700805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of cyclosporin A into the rabbit cornea and aqueous humor after topical drop and collagen shield administration.
    Kanpolat A; Batioglu F; Yilmaz M; Akbas F
    CLAO J; 1994 Apr; 20(2):119-22. PubMed ID: 8044977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depot drug delivery system for 5-fluorouracil after filtration surgery in the rabbit.
    Trope GE; Cheng YL; Sheardown H; Liu GS; Menon IA; Heathcote JG; Rootman DS; Chiu WJ; Gould L
    Can J Ophthalmol; 1994 Dec; 29(6):263-7. PubMed ID: 7834564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of collagen cross-linking in collagen corneal shields on ocular drug delivery.
    Kuwano M; Horibe Y; Kawashima Y
    J Ocul Pharmacol Ther; 1997 Feb; 13(1):31-40. PubMed ID: 9029438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wound modulation after trabeculectomy by different formulations of antimetabolites in rabbits.
    Lu DW; Chang CJ; Chiang CH; Yeh MK; Chou PI
    J Ocul Pharmacol Ther; 2000 Dec; 16(6):529-38. PubMed ID: 11132900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subconjunctival 5-fluorouracil polyphase liposome interference with scar formation in experimental filtration surgery].
    Jing M; Xi S; Chen R
    Zhonghua Yan Ke Za Zhi; 1996 Jan; 32(1):49-52. PubMed ID: 8758392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen shields delivery of netilmicin: a study of ocular pharmacokinetics.
    Dorigo MT; De Natale R; Miglioli PA
    Chemotherapy; 1995; 41(1):1-4. PubMed ID: 7875016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The collagen shield as a collagenase inhibitor and clinical indicator of collagenase activity on the ocular surface.
    Schiff WM; Speaker MG; McCormick SA
    CLAO J; 1992 Jan; 18(1):59-63. PubMed ID: 1313747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.